CSF2 and neoplasm: Tumor cell immunogenicity in vivo has been improved through the increased expression of immune-modulatory proteins, such as cytokine genes IL-2, IL-12, and granulocyte macrophage colony stimulating factor (GMCSF) (150, 151).